. Store-operated calcium entry (SOCE) constitutes a major calcium entry pathway in mammals to control lymphocyte activation, muscle contraction, gene expression and cell metabolism. The calcium release- activated calcium (CRAC) channel composed of ORAI-STIM represents a prototypical example of SOCE in lymphocytes. The clinical relevance of SOCE is exemplified by two human diseases, the severe combined immunodeficiency (SCID) and tubular aggregate myopathy (TAM), which are caused by loss- or gain-of-function mutations in ORAI1 and STIM1, respectively. Augmented SOCE is also implicated in cardiovascular disorders and cancer metastasis. Therefore, CRAC channel has been pursued as an attractive drug target for therapeutic intervention. Tremendous efforts have been directed to establish ORAI-STIM as the minimal two-component system to couple ER calcium store depletion with calcium influx across the plasma membrane. The regulatory machinery dedicated to the ORAI-STIM signaling, nonetheless, still remains incompletely defined. In this proposal, the PI aims to bridge this critical knowledge gap by unveiling the functions of two novel SOCE modulators, which reside at distinct subcellular locations to act on different steps of ORAI-STIM signaling: the initial activation of STIM within the ER lumen and the later stabilization of ORAI-STIM complexes at ER-PM membrane contact sites (MCS), where the close appositions of two membranes are separated by a gap distance of 10-30 nm.
In Aim 1, based on preliminary findings from proteomic profiling of potential STIM1 interactors within the ER lumen, the PI will define how a previously-unrecognized multiple EF-hand protein cooperates with the luminal domain of STIM1 (EFSAM) to shape the activation and deactivation kinetics of SOCE. The PI will employ a new ?ER-to-PM? trafficking strategy to expose the luminal domain toward the extracellular side, thereby overcoming a major impediment to studies on the liminal sides of ER-resident signaling proteins.
In Aim 2, capitalizing on the discovery of a TMEM family protein as a regulator of calcium influx at ER-PM MCS, the PI will define how this modulator responds to physiological stimuli to remodel the assembly of ER-PM junctions and PIP homeostasis to sustain SOCE. The generation of innovative optogenetic tools and a transgenic mouse model to dissect calcium signaling and protein-PIP interactions will further accelerate our structure-function relationship studies on these novel regulators. Overall, the new mechanistic insights gained through the proposed study will lead to advances in the constantly-revitalized field of calcium signaling, and in parallel, spawn the vibrant field of membrane contact sites. In the long run, discoveries made in the study can be translated into the development of effective therapeutics targeting aberrant calcium and phosphoinositide signaling.

Public Health Relevance

) The proposed research is directly relevant to public health and the NIH?s mission of developing fundamental knowledge that will help to reduce the burdens of human disability. The overall goal of this project is to unravel the molecular controlling and regulatory mechanisms of store- operated calcium entry, an indispensable pathway that constitutes the primary calcium entry route in human cells. Dysregulated calcium entry is directly linked to pathological conditions such as immunodeficiency, muscle dysfunction, and cancer metastasis; thus, targeting aberrant calcium signaling holds great therapeutic potential for the treatment of these human disorders. ! !

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM112003-06
Application #
9661826
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Nie, Zhongzhen
Project Start
2014-08-01
Project End
2023-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Internal Medicine/Medicine
Type
Overall Medical
DUNS #
835607441
City
College Station
State
TX
Country
United States
Zip Code
77845
Zhang, Yiming; Zheng, Sisi; Zhou, Yubin et al. (2018) Patch-Clamp Recording of the CRAC Channel Current in STIM-Orai Overexpressing Cells. Methods Mol Biol 1843:1-16
Nguyen, Nhung T; Han, Weidong; Cao, Wen-Ming et al. (2018) Store-Operated Calcium Entry Mediated by ORAI and STIM. Compr Physiol 8:981-1002
Nguyen, Nhung Thi; Ma, Guolin; Lin, Eena et al. (2018) CRAC channel-based optogenetics. Cell Calcium 75:79-88
Ma, Guolin; Liu, Jindou; Ke, Yuepeng et al. (2018) Optogenetic Control of Voltage-Gated Calcium Channels. Angew Chem Int Ed Engl 57:7019-7022
Li, Jia; Wu, Xinwei; Zhou, Yubin et al. (2018) Decoding the dynamic DNA methylation and hydroxymethylation landscapes in endodermal lineage intermediates during pancreatic differentiation of hESC. Nucleic Acids Res 46:2883-2900
Chauhan, Anoop Singh; Liu, Xiaoguang; Jing, Ji et al. (2018) STIM2 interacts with AMPK and regulates calcium-induced AMPK activation. FASEB J :fj201801225R
Ma, Guolin; He, Lian; Jing, Ji et al. (2018) Engineered Cross-Linking to Study the Pore Architecture of the CRAC Channel. Methods Mol Biol 1843:147-166
Zhang, Jixiang; Tan, Peng; Guo, Lei et al. (2018) p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance. Oncogene :
Ma, Guolin; Zhang, Qian; He, Lian et al. (2018) Genetically encoded tags for real time dissection of protein assembly in living cells. Chem Sci 9:5551-5555
Nguyen, Nhung Thi; He, Lian; Martinez-Moczygemba, Margarita et al. (2018) Rewiring Calcium Signaling for Precise Transcriptional Reprogramming. ACS Synth Biol 7:814-821

Showing the most recent 10 out of 38 publications